Literature DB >> 18626794

Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.

Carmit Nadri1, Galila Agam.   

Abstract

Synaptophysin, a synaptic vesicle protein and a marker for synaptic density has been found to be reduced in postmortem prefrontal cortex of schizophrenia patients, consistent with evidence for synaptic deficits in schizophrenia. The contribution of both genetic and environmental factors to the etiology of schizophrenia is well established, and obstetric complications have been suggested as a non-genetic risk factor of schizophrenia. As there is only scarce evidence for a genetic linkage between synaptophysin's chromosomal locus (Xp11.22) and schizophrenia, we hypothesized that early neonatal exposure of rat pups to oxygen restriction would result in reduced frontal cortex synaptophysin protein levels at adulthood. We studied the effects of anoxia or hypoxia on 7-day-old rats frontal cortex synaptophysin protein levels assessed by Western blotting 4 and 7 weeks following the exposure. In hypoxia- or anoxia-exposed rats, synaptophysin protein levels were elevated both 4 and 7 weeks after the exposure. Two-way ANOVA followed by post hoc LSD analysis showed that the effect was predominantly at 4 weeks after exposure and that only anoxia-exposed rats differed significantly from control rats (p = 0.019). These results are in contrast to postmortem findings in schizophrenia and suggest that reduced synaptophysin protein levels in schizophrenia patients' postmortem brain do not result from perinatal oxygen deprivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626794     DOI: 10.1007/s12031-008-9120-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  53 in total

1.  Effects of perinatal anoxia on the acute locomotor response to repeated amphetamine administration in adult rats.

Authors:  W G Brake; P Boksa; A Gratton
Journal:  Psychopharmacology (Berl)       Date:  1997-10       Impact factor: 4.530

2.  Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness.

Authors:  W G Honer; P Falkai; C Chen; V Arango; J J Mann; A J Dwork
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

3.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

Review 4.  Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology.

Authors:  Hélène Verdoux; Anne-Laure Sutter
Journal:  Am J Med Genet       Date:  2002-12-08

5.  Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling.

Authors:  M J Decker; G E Hue; W M Caudle; G W Miller; G L Keating; D B Rye
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

6.  Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.

Authors:  S L Eastwood; P W Burnet; P J Harrison
Journal:  Neuroscience       Date:  1995-05       Impact factor: 3.590

Review 7.  Fetal and neonatal origins of altered brain development.

Authors:  Sandra Rees; Terrie Inder
Journal:  Early Hum Dev       Date:  2005-09       Impact factor: 2.079

8.  Altered catecholaminergic behavioral and hormonal responses in rats following early postnatal hypoxia.

Authors:  R H Hermans; L D Longo
Journal:  Physiol Behav       Date:  1994-03

9.  Anoxic and hypoxic immature rat model for measurement of monoamine using in vivo microdialysis.

Authors:  W Nakajima; A Ishida; G Takada
Journal:  Brain Res Brain Res Protoc       Date:  1999-01

Review 10.  Animal models of obstetric complications in relation to schizophrenia.

Authors:  Patricia Boksa
Journal:  Brain Res Brain Res Rev       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.